 |
| Algeta ASA is a therapeutics company built on world-leading expertise in nuclear medicine and oncology and dedicated to the development of novel anticancer therapeutics based on alpha particle emitting radionuclides. |  |
Intraday
| Info | Bid | Ask | Last | Time | High | Low | Profit % today | Amount (MNOK) | Market cap (MNOK) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 209.70 | 209.90 | 209.70 | 14:20 | 210.10 | 201.10 | -2.10% | 51.77 | 9,178.92 |
Historical prices
| Period | Ret. % | High | Low |
|---|---|---|---|
| Intraday | -2.10% | 210.10 | 201.10 |
| Week | -0.85% | 245.40 | 200.00 |
| Month | 7.81% | 245.40 | 191.20 |
| This year | 35.47% | 245.40 | 156.10 |
| 1 year | 50.86% | 245.40 | 131.00 |
| Order depth | 22.05.2013 14:20:41 |
|---|
| Volume | Bid | Ask | Volume | ||
|---|---|---|---|---|---|
| 147 | 209.70 |  |  | 209.90 | 283 |
| 14 | 209.60 | | | 210.00 | 2,763 |
| 450 | 209.50 | | | 210.10 | 1,000 |
| 51 | 209.10 | | | 210.30 | 469 |
| 1,170 | 209.00 | | | 210.50 | 100 |
Last trades
| Date | Price | Volume | Buyer | Seller |
|---|---|---|---|---|
| 14:20 | 209.70 | 120 | DBL | DNM |
| 14:20 | 209.70 | 91 | MSI | DNM |
| 14:20 | 209.90 | 202 | FSE | DNM |
| 14:20 | 209.90 | 198 | FSE | JPM |
| 14:20 | 209.90 | 86 | FSE | UBS |
| 14:20 | 209.90 | 221 | FSE | DNM |
| 14:20 | 209.90 | 492 | FSE | MLI |
| 14:20 | 209.90 | 1 | FSE | UBS |
| 14:20 | 209.80 | 19 | UBS | NIP |
| 14:20 | 209.80 | 90 | UBS | NIP |
| 14:20 | 209.80 | 101 | MSI | NIP |
| 14:20 | 209.80 | 71 | MSI | NIP |
| 14:20 | 209.80 | 89 | MSI | MLI |
| 14:20 | 209.80 | 18 | MSI | DNM |
| 14:20 | 209.80 | 76 | MSI | DNM |